Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3487, Durham, NC 27710
Phone (919) 660-6626
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine, Director of the Duke Hypertension Center, Director of Clinical Research at the Sarah W. Stedman Nutrition and Metabolism Center, Vice Chair for Faculty Development and Diversity in the Department of Medicine. She is also the Director of Duke’s CTSA internal career development award program (KL2).She is a faculty member of the Duke Molecular Physiology Institute (DMPI) and the Cardiovascular Research Center (CVRC). She is co-Director of the Clinical and Translational Core of the Duke O’Brien Center for Kidney Research (DOCK).

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is a member of the Association of American Physicians (AAP).

Dr. Svetkey is Vice Chair for Faculty Development and Diversity in the Department of Medicine.  In this role she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Appel, L. J., D. W. Harsha, F. M. Sacks, L. P. Svetkey, E. Obarzanek, G. A. Bray, M. Aickin, P. R. Conlin, and E. R. Miller. “Moderate sodium reduction has no effect on blood lipids: Results of the DASH-sodium trial.” In Hypertension, 42:446–446. LIPPINCOTT WILLIAMS & WILKINS, 2003.

Scholars@Duke

McCarthy, William J., Thalida Em Arpawong, Barbara J. Dietsch, and Antronette K. Yancey. “Effects of exercise and weight loss on hypertension..” Jama 290, no. 7 (August 20, 2003). https://doi.org/10.1001/jama.290.7.885-a.

PMID
12928458
Full Text

Akita, Sachie, Frank M. Sacks, Laura P. Svetkey, Paul R. Conlin, Genjiro Kimura, and Genjiro DASH-Sodium Trial Collaborative Research Group. “Effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the pressure-natriuresis relationship..” Hypertension 42, no. 1 (July 2003): 8–13. https://doi.org/10.1161/01.HYP.0000074668.08704.6E.

PMID
12756219
Full Text

Svetkey, Laura P., David W. Harsha, William M. Vollmer, Victor J. Stevens, Eva Obarzanek, Patricia J. Elmer, Pao Hwa Lin, et al. “Premier: a clinical trial of comprehensive lifestyle modification for blood pressure control: rationale, design and baseline characteristics..” Ann Epidemiol 13, no. 6 (July 2003): 462–71.

PMID
12875806
Scholars@Duke

Sacks, Frank M., Lawrence J. Appel, George A. Bray, Paul R. Conlin, Thomas J. Moore, Laura P. Svetkey, and William M. Vollmer. “Sodium and blood pressure: no data dredging, please!.” Am J Hypertens 16, no. 7 (July 2003): 614–16. https://doi.org/10.1016/s0895-7061(03)00855-0.

PMID
12850399
Full Text

Conlin, P. R., T. P. Erlinger, A. Bohannon, E. R. Miller, L. J. Appel, L. P. Svetkey, and T. J. Moore. “The DASH diet enhances the blood pressure response to losartan in hypertensive patients.” American Journal of Hypertension 16, no. 5 I (May 1, 2003): 337–42. https://doi.org/10.1016/S0895-7061(03)00056-6.

Full Text

Conlin, Paul R., Thomas P. Erlinger, Arline Bohannon, Edgar R. Miller, Lawrence J. Appel, Laura P. Svetkey, and Thomas J. Moore. “The DASH diet enhances the blood pressure response to losartan in hypertensive patients..” Am J Hypertens 16, no. 5 Pt 1 (May 2003): 337–42. https://doi.org/10.1016/s0895-7061(03)00056-6.

PMID
12745193
Full Text

ARD, J. “1-year follow-up results for participants who completed the DASH-Sodium trial.” In American Journal of Hypertension, 16:A158–59. Oxford University Press (OUP), 2003. https://doi.org/10.1016/s0895-7061(03)00500-4.

Full Text

SVETKEY, L. “Premier trial: BP effects of lifestyle interventions in subgroups.” In American Journal of Hypertension, 16:A28–A28. Oxford University Press (OUP), 2003. https://doi.org/10.1016/s0895-7061(03)00144-4.

Full Text

Appel, Lawrence J., Catherine M. Champagne, David W. Harsha, Lawton S. Cooper, Eva Obarzanek, Patricia J. Elmer, Victor J. Stevens, et al. “Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial..” Jama 289, no. 16 (April 23, 2003): 2083–93. https://doi.org/10.1001/jama.289.16.2083.

PMID
12709466
Full Text

Pages